SITC Clinical Immuno-Oncology Network (SCION) commentary on measurement and interpretation of essential biomarkers in early clinical trials

Related Posts

• Multiplex imaging in immuno-oncology

  Multiplex imaging has emerged as an invaluable tool for immune-oncologists and translational researchers, enabling them…

• Next-generation ctDNA-driven clinical trials in precision immuno-oncology

• [Policy Review] Current drug development and trial designs in neuro-oncology: report from the first American Society of Clinical Oncology and Society for Neuro-Oncology Clinical Trials Conference

  Successful drug development for people with cancers of the CNS has been challenging. There are…